Related Experiment Videos

Vogt-Koyanagi-Harada syndrome in children compared to adults

K F Tabbara1, P S Chavis, W R Freeman

  • 1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Insights

Vogt-Koyanagi-Harada (VKH) syndrome in children presents aggressively, leading to more severe ocular complications and poorer visual outcomes compared to adults. Early-onset VKH requires urgent attention due to its severe impact on vision.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Immunology

Background:

  • Vogt-Koyanagi-Harada (VKH) syndrome is a rare, idiopathic, systemic inflammatory disorder affecting pigmented tissues.
  • VKH syndrome commonly affects young adults but can occur at any age, including childhood.

Purpose of the Study:

  • To investigate the clinical course and visual prognosis of Vogt-Koyanagi-Harada (VKH) syndrome in pediatric patients.
  • To compare the outcomes of early-onset VKH (before age 14) with adult-onset VKH.

Main Methods:

  • Retrospective review of 97 consecutive VKH patients treated at King Khaled Eye Specialist Hospital.
  • Patients were categorized into pediatric (onset ≤14 years) and adult (onset >14 years) groups.
  • Comparison of ocular complications, treatment requirements, and final visual acuity between the two groups.

Main Results:

  • Pediatric VKH patients exhibited a higher rate of cataract surgery (61% vs. 17%) compared to adults.
  • A significantly greater proportion of children experienced severe visual impairment (final visual acuity ≤20/200) at 61% versus 26% in adults (p=0.0103).
  • Ocular complications and vision deterioration were more pronounced in the pediatric group despite therapy.

Conclusions:

  • Early-onset Vogt-Koyanagi-Harada (VKH) syndrome, occurring before age 14, follows an aggressive clinical course.
  • Children with VKH syndrome experience more severe ocular complications and poorer visual outcomes than adult patients.
  • Aggressive management is crucial for VKH syndrome in children to mitigate severe and potentially irreversible vision loss.
Abstract

Related Concept Videos